JVJavier Vargas-Villarreal

Javier Vargas-Villarreal

*This is an algorithmically generated author record based on publicly available information.

Javier Vargas-Villarreal has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Identificación y evaluación de actividad de Fosfolipasas A1 y A2 en extractos de Trichomonas tenax

    by Javier Vargas-Villarreal, Edna M. García-Muñoz, Carlos E. Hernández-Luna, José A. Heredia-Rojas, Abraham O. Rodríguez-De la Fuente, Ofelia Monsiváis-Diaz, Virginia Martínez-Gaytán, Francisco González-Salazar, Marlene M. Perales-Quintana, Francisco J. Guzmán-De la Garza

    Resumen Antecedentes. Trichomonas tenax (T. tenax) se encuentra en la boca de sujetos con mala higiene bucal, generalmente se asocia con la presencia de enfermedad periodontal; sin embargo y a pesar de que se considera un organismo comensal puede ocasionar daño celular. Este es el primer reporte que evidencia actividad de fosfolipasas A 1 y A 2 en extractos de T. tenax. Objetivo. Identificar la actividad enzimática tipo fosfolipasa en extractos y fracciones obtenidas de cultivos axénicos de T. tenax; y evaluar la relación y dependencia con el tiempo de incubación, la dosis, el pH y el calcio. Métodos. Se determinó la actividad de fosfolipasas en extractos de T. tenax cultivados en medio TYI-S-33; y se evaluó la relación tiempo-actividad, dosis-actividad, pH-actividad y calcio-actividad después de la incubación a 37°C. Resultados. Las actividades tipo fosfolipasa A 1 y A 2 están presentes en la fracción subcelular, y en el sobrenadante, aumentan cuando se incrementa su concentración (contenido proteico del extracto), es máxima a los 120 min, con pH = 8 y depende de Ca +. Conclusiones.

  • Open Access

    Furanocoumarins from Ruta chalepensis with Amebicide Activity

    by Aldo Fabio Bazaldúa-Rodríguez, Ramiro Quintanilla-Licea, María Julia Verde-Star, Magda Elizabeth Hernández-García, Javier Vargas-Villarreal, Jesús Norberto Garza-González

    Entamoeba histolytica (protozoan; family Endomoebidae) is the cause of amoebiasis, a disease related to high morbidity and mortality. Nowadays, this illness is considered a significant public health issue in developing countries. In addition, parasite resistance to conventional medicinal treatment has increased in recent years. Traditional medicine around the world represents a valuable source of alternative treatment for many parasite diseases. In a previous paper, we communicated about the antiprotozoal activity in vitro of the methanolic (MeOH) extract of Ruta chalepensis (Rutaceae) against E. histolytica. The plant is extensively employed in Mexican traditional medicine. The following workup of the MeOH extract of R. chalepensis afforded the furocoumarins rutamarin (1) and chalepin (2), which showed high antiprotozoal activity on Entamoeba histolytica trophozoites employing in vitro tests (IC50 values of 6.52 and 28.95 µg/mL, respectively). Therefore, we offer a full scientific report about the bioguided isolation and the amebicide activity of chalepin and rutamarin.


  • Open Access

    Antiprotozoal Activity Against Entamoeba histolytica of Flavonoids Isolated from Lippia graveolens Kunth

    by Ramiro Quintanilla-Licea, Javier Vargas-Villarreal, María Julia Verde-Star, Verónica Mayela Rivas-Galindo, Ángel David Torres-Hernández

    Amebiasis caused by Entamoeba histolytica is nowadays a serious public health problem worldwide, especially in developing countries. Annually, up to 100,000 deaths occur across the world. Due to the resistance that pathogenic protozoa exhibit against commercial antiprotozoal drugs, a growing emphasis has been placed on plants used in traditional medicine to discover new antiparasitics. Previously, we reported the in vitro antiamoebic activity of a methanolic extract of Lippia graveolens Kunth (Mexican oregano). In this study, we outline the isolation and structure elucidation of antiamoebic compounds occurring in this plant. The subsequent work-up of this methanol extract by bioguided isolation using several chromatographic techniques yielded the flavonoids pinocembrin (1), sakuranetin (2), cirsimaritin (3), and naringenin (4). Structural elucidation of the isolated compounds was achieved by spectroscopic/spectrometric analyses and comparing literature data. These compounds revealed significant antiprotozoal activity against E. histolytica trophozoites using in vitro tests, showing a 50% inhibitory concentration (IC50) ranging from 28 to 154 µg/mL. Amebicide activity of sakuranetin and cirsimaritin is reported for the first time in this study. These research data may help to corroborate the use of this plant in traditional Mexican medicine for the treatment of dyspepsia.


  • Open Access

    In Vitro Study of Antiamoebic Activity of Methanol Extracts ofArgemone mexicanaon Trophozoites ofEntamoeba histolyticaHM1-IMSS

    by Joel H. Elizondo-Luévano, Rocío Castro-Ríos, Eduardo Sánchez-García, Magda E. Hernández-García, Javier Vargas-Villarreal, Osvelia E. Rodríguez-Luis, Abelardo Chávez-Montes

    Infections caused by parasites in humans represent one of the main public health concerns. Amoebiasis, a parasitic infection caused byEntamoeba histolytica(E. histolytica), is considered endemic in Mexico, whereArgemone mexicana(A. mexicana) has been used in traditional medicine to treat intestinal parasitic diseases. The objective of this work was to evaluate the potential biological activity ofA. mexicanaonE. histolytica. For this purpose, a methanolic extract was prepared fromA. mexicanaleaves, and a differential fractionation was carried out with solvents of different polarities. The inhibitory capacities of the extract and its fractions were evaluated in vitro using HM1-IMSS, a strain ofEntamoeba histolytica.A. mexicanaextract was found to have a growth-inhibiting activity forE. histolytica, showing IC50 = 78.39 μg/mL. The extract was characterized phytochemically, and the methanolic extract fractions were analyzed by liquid chromatography (HPLC) and mass spectrometry (MS). Berberine and jatrorrhizine were present in the active fractions, and these compounds may be responsible for the antiparasitic activity. The identification of amoebicidal activity ofA. mexicanaonE. histolyticagives support to the traditional use. Further studies with berberine and jatrorrhizine will be carried out to understand the mechanism involved.


  • Open Access

    “CLUPS”: A New Culture Medium for the Axenic Growth ofEntamoeba histolytica

    by F. Gonzalez-Salazar, I. Meester, F. J. Guzmán De La Garza, L. H. De La Garza-Salinas, A. Sampayo-Reyes, J. N. Garza-Gonzalez, O. Monsivais-Diaz, B. A. Barba-Dávila, M. E. Hernández-García, J. Vargas-Villarreal

    Amebiasis remains a major health problem in Mexico. Therefore, the search for better culture media and low-cost diagnostic and therapeutic tools is fundamental. We present a new culture medium forEntamoeba histolyticawhich allows the microbe to preserve its virulence factors and ability to induce hepatic abscesses in animal models. The novel CLUPS medium is an improved version of the PEHPS medium, previously designed in our laboratory. The main difference is the substitution of raw beef liver in PEHPS by raw beef lung in the CLUPS medium. To compare the performance of three-culture media (traditional TYI-S-33, PEHPS, and CLUPS),E. histolyticatrophozoites were cultured in quintuplicate, followed by the evaluation of phospholipase activity and the induction of liver abscesses in golden hamsters.E. histolyticatrophozoites grew significantly better in CLUPS medium than in TYI-S-33. Likewise, CLUPS-cultured trophozoites produced significantly more phospholipases than TYI-S-33-cultured trophozoites. Finally, trophozoites grown in any of the three tested media had similar potential to induce liver abscesses.


  • Modeling tuberculosis pathogenesis through ex vivo lung tissue infection

    by Pilar Carranza-Rosales, Irma Edith Carranza-Torres, Nancy Elena Guzmán-Delgado, Gerardo Lozano-Garza, Licet Villarreal-Treviño, Carmen Molina-Torres, Javier Vargas Villarreal, Lucio Vera-Cabrera, Jorge Castro-Garza


  • Effect of Bismuth Lipophilic Nanoparticles (BisBAL NPs) on Trichomonas vaginalis Growth

    by Osvelia E Rodríguez-Luis, Rene Hernández-Delgadillo, Nayely Pineda-Aguilar, Javier Vargas-Villarreal, Francisco González-Salazar, Jesús Norberto Garza-González, Magda Elizabeth Hernández-García, Shankararaman Chellam, Claudio Cabral-Romero

    The most common treatment to trichomoniasis is the use of metronidazole; however several studies have shown that at least 5% of clinical cases of trichomoniasis are caused by parasites resistant to the drug. Lipophilic bismuth nanoparticles (BisBAL NPs) have an important antimicrobial activity; however the influence of BisBAL NPs on human parasites has not been studied. The objective of this study was to determine the effect of bismuth lipophilic nanoparticles on Trichomonas vaginalis growth. The bismuth nanoparticles synthesized by colloidal method are composed of ≥ 100 nm crystallites and have a spherical structure, agglomerating into clusters of small nanoparticles. Based on cell viability assays and fluorescence microscopy, Trichomonas vaginalis growth was inhibited with the addition of 62.5–125 μg/mL of BisBAL NPs. Fluorescence micrographs showed live T. vaginalis in absence of any drug treatment and after exposed for 24 h. with 500 μg/mL of BisBAL NPs or 1.3 μg/mL metronidazole a dark background was observed with cellular debris stain. In summary, here we present evidence for first time of the antiparasitic activity of lipophilic bismuth nanoparticles being as effective as metronidazole to interfere with T. vaginalis growth. BisBAL nanoparticles could be an interesting alternative to treat and prevent parasitic infections.


  • Antiprotozoal activity against Entamoeba histolytica of furocoumarins isolated from Ruta chalepensis

    by R Quintanilla-Licea, Bd Mata-Cárdenas, J Vargas-Villarreal, Af Bazaldúa-Rodríguez, Mj Verde-Star

    Amoebiasis caused by Entamoeba histolytica, a protozoan of the family Endomoebidae is associated with high morbidity and mortality and is therefore considered as the third parasitosis of medical importance after malaria and schistosomiasis [1, 2]. Currently metronidazole is the therapeutic drug of choice for the treatment of amoebiasis, but is experiencing drug resistance by E. histolytica, resulting in the need for increased doses to overcome the infection and thus causing unpleasant side effects. For this reason new, more effective and safer antiprotozoal agents are urgently required [3]. We reported shortly the antiamoebic activity in vitro of the methanolic extract of Ruta chalepensis (Rutaceae) [4] and we are now reporting the bioguided isolation of compounds with amebicide activity from this plant. Partition of the methanolic extract of Ruta chalepensis by extraction with n-hexane led to a residue with good activity against E. histolytica (93.0% growth inhibition). Chromatography of this hexane residue over a silica gel column led to the isolation of chalepensin (1), whereas the following work up of the methanol residue by partition between methanol and ethyl acetate followed by chromatography of the EtOAc residue (84.8% growth inhibition) over a silica gel column afforded chalepin (2) and rutamarin (3) as well as the isoquinoline alkaloid graveoline (4). Identification of the isolated compounds was based on spectroscopic/spectrometric analyses and comparison with literature data. These compounds were tested for antiprotozoal activity against E. histolytica tropohzoites using in vitro tests. Vials were incubated for 72h. The inhibition percentage was estimated as the number of dead cells compared with the untreated controls. IC50 of these compounds was determined by using a Probit analysis with a 95% confidence level. The isolated furocoumarins (Figure 1) from R. chalepensis displayed more than 90% growth inhibition against E. histolytica at a concentration of 150 µg/mL, with IC50 values ranging from 6.54 to 38.71 µg/mL, far less effective than metronidazole (IC50 0.205 µg/mL), but these IC50 values are suitable as selection criterion for further investigation of this plant as source of potential antiprotozoal agents. Graveoline did not show amebicide activity. Acknowledgements: The authors would like to thank the DAAD (Germany), who financed a stay of R.Q.L. at the University of Göttingen, and to CONACYT (Mexico) for doctoral fellowship awarded to A.F.B.R. Keywords: neglected diseases, amoebiasis, Mexican medicinal plants, antiprotozoal agents. References: [1] Hotez PJ, Woc-Colburn L, Bottazzi ME. Neglected tropical diseases in Central America and Panama: Review of their prevalence, populations at risk and impact on regional development. Int J Parasitol 2014; 44: 597 – 603 [2] Bansal D, Sehgal R, Chawla Y, Malla N, Mahajan RC. Multidrug resistance in amoebiasis patients. Indian J Med Res 2006; 124: 189 – 194 [3] Singh S, Bharti N, Mohapatra PP. Chemistry and biology of synthetic and naturally occurring antiamoebic agents. Chem Rev 2009; 109: 1900 – 1947 [4] Quintanilla-Licea R, Mata-Cárdenas BD, Vargas-Villarreal J, Bazaldúa-Rodríguez AF, Ángeles-Hernández IK, Garza-González JN, Hernández-García ME. Antiprotozoal activity against Entamoeba histolytica of plants used in northeast Mexican traditional medicine. bioactive compounds from Lippia graveolens and Ruta chalepensis. Molecules 2014; 19: 21044 – 21065


  • Open Access

    An acidic sphingomyelinase Type C activity from Mycobacterium tuberculosis

    by Jorge Castro-Garza, Francisco González-Salazar, Frederick D. Quinn, Russell K. Karls, Laura Hermila De La Garza-Salinas, Francisco J. Guzmán-De la Garza, Javier Vargas-Villarreal


  • Open Access

    Antiprotozoal Activity against Entamoeba histolytica of Plants Used in Northeast Mexican Traditional Medicine. Bioactive Compounds from Lippia graveolens and Ruta chalepensis

    by Ramiro Quintanilla-Licea, Benito David Mata-Cárdenas, Javier Vargas-Villarreal, Aldo Fabio Bazaldúa-Rodríguez, Isvar Kavimngeles-Hernández, Jesús Norberto Garza-González, Magda Elizabeth Hernández-García

    Amoebiasis caused by Entamoeba histolytica is associated with high morbidity and mortality is becoming a major public health problem worldwide, especially in developing countries. Because of the side-effects and the resistance that pathogenic protozoa build against the standard antiparasitic drugs, e.g., metronidazole, much recent attention has been paid to plants used in traditional medicine around the world in order to find new antiprotozoal agents. We collected 32 plants used in Northeast Mexican traditional medicine and the methanolic extracts of these species were screened for antiprotozoal activity against E. histolytica trophozoites using in vitro tests. Only 18 extracts showed a significant inhibiting activity and among them six plant extracts showed more than 80% growth inhibition against E. histolytica at a concentration of 150 µg/mL and the IC50 values of these extracts were determined. Lippia graveolens Kunth and Ruta chalepensis Pers. showed the more significant antiprotozoal activity (91.54% and 90.50% growth inhibition at a concentration of 150 µg/mL with IC50 values of 59.14 and 60.07 µg/mL, respectively). Bioassay-guided fractionation of the methanolic extracts from these two plants afforded carvacrol (1) and chalepensin (2), respectively, as bioactive compounds with antiprotozoal activity.